This webinar highlights the progress and future directions of neurodegenerative disease biomarkers. Dr. Arnold discusses CSF and blood biomarkers for Alzheimer’s diagnosis and prognosis, emphasizing the need for additional non-amyloid/tau markers. Dr. Venkat reviews the evolution of AD biomarker assays and the potential of neurofilament heavy chain in ALS.
Steven E. Arnold, MD
Professor of Neurology, Harvard Medical School
Translational Neurology Head and Managing Director, Interdisciplinary Brain Center
Massachusetts General Hospital
Iswariya Venkataman, PhD
Scientific Affairs, EUROIMMUN US
To view this webinar, please complete the following form.
2024 EUROIMMUN US
